Decreased affinity of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL) D269H/E195R to osteoprotegerin (OPG) overcomes trail resistance mediated by the bone microenvironment

17Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: The bone marrow environment secretes OPG and can thereby prevent TRAIL-induced apoptosis in multiple myeloma. Results: rhTRAIL D269H/E195R shows a decreased affinity to OPG and induces apoptosis in multiple myeloma cells in the presence of OPG. Conclusion: Apoptosis induction by rhTRAIL D269H/E195R is not inhibited by OPG. Significance: rhTRAIL D269H/E195R can be used as potential therapy for multiple myeloma. © 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Cite

CITATION STYLE

APA

Bosman, M. C. J., Reis, C. R., Schuringa, J. J., Vellenga, E., & Quax, W. J. (2014). Decreased affinity of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL) D269H/E195R to osteoprotegerin (OPG) overcomes trail resistance mediated by the bone microenvironment. Journal of Biological Chemistry, 289(2), 1071–1078. https://doi.org/10.1074/jbc.M113.491589

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free